Document is current
Any future updates will be listed below
-
Authors
Ali, Adel Hajj
Ichkhanian, Yervant
Sloan, Joshua A.
Azeem, Nabeel
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 22 October 2025
First Online: 2 November 2025
Declarations
:
: Joshua A Sloan: Sanofi-Regeneron: speakers bureau, and advisory board; Phathom pharmaceuticals: advisory board; Takeda Pharmaceuticals: advisory board; Current Treatment Options in Gastroenterology: section editor.
: The authors declare no competing interests.
